Growth Metrics

Innoviva (INVA) EBITDA Margin (2016 - 2026)

Innoviva filings provide 15 years of EBITDA Margin readings, the most recent being 32.08% for Q3 2025.

  • On a quarterly basis, EBITDA Margin fell 1623.0% to 32.08% in Q3 2025 year-over-year; TTM through Sep 2025 was 30.79%, a 1148.0% decrease, with the full-year FY2025 number at 39.81%, down 671.0% from a year prior.
  • EBITDA Margin hit 32.08% in Q3 2025 for Innoviva, down from 48.61% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 8265.41% in Q2 2021 to a low of 1668.23% in Q1 2025.
  • Median EBITDA Margin over the past 5 years was 489.64% (2022), compared with a mean of 55.98%.
  • Biggest five-year swings in EBITDA Margin: soared 816941bps in 2021 and later crashed -875506bps in 2022.
  • Innoviva's EBITDA Margin stood at 611.53% in 2021, then crashed by -61bps to 982.68% in 2022, then skyrocketed by 56bps to 430.5% in 2023, then crashed by -98bps to 853.36% in 2024, then soared by 104bps to 32.08% in 2025.
  • The last three reported values for EBITDA Margin were 32.08% (Q3 2025), 48.61% (Q2 2025), and 1668.23% (Q1 2025) per Business Quant data.